Voshol P J, Schwarz M, Rigotti A, Krieger M, Groen A K, Kuipers F
Groningen University Institute for Drug Exploration, Center for Liver, Digestive and Metabolic Diseases, University Hospital Groningen, Hanzeplein 1, NL-9713 GZ Groningen, The Netherlands.
Biochem J. 2001 Jun 1;356(Pt 2):317-25. doi: 10.1042/0264-6021:3560317.
Scavenger receptor class B, type I (SR-BI) is expressed in the intestines of rodents and has been suggested to be involved in the absorption of dietary cholesterol. The aim of this study was to determine whether intestinal SR-BI expression is affected in animal models with altered bile delivery to the intestine and impaired cholesterol absorption. SR-BI protein and mRNA levels were determined in proximal and distal small intestine from control, bile-duct-ligated and bile-diverted rats and from control and bile-duct-ligated mice. Two genetically altered mouse models were studied: multidrug resistance-2 P-glycoprotein-deficient [Mdr2((-/-))] mice that produce phospholipid/cholesterol-free bile, and cholesterol 7alpha-hydroxylase-deficient [Cyp7a((-/-))] mice, which exhibit qualitative and quantitative changes in the bile-salt pool. Cholesterol-absorption efficiency was quantified using a dual-isotope ratio method. SR-BI was present at the apical membrane of enterocytes in control rats and mice and was more abundant in proximal than in distal segments of the intestine. In bile-duct-ligated animals, levels of SR-BI protein were virtually absent and mRNA levels were decreased by approximately 50%. Bile-diverted rats, Mdr2((-/-)) mice and Cyp7a((-/-)) mice showed decreased levels of intestinal SR-BI protein while mRNA levels were unaffected. Cholesterol absorption was reduced by >90% in bile-duct-ligated and bile-diverted animals and in Cyp7a((-/-)) mice, whereas Mdr2((-/-)) mice showed an approximately 50% reduction. This study shows that SR-BI is expressed at the apical membrane of enterocytes of rats and mice, mainly in the upper intestine where cholesterol absorption is greatest, and indicates that bile components play a role in post-transcriptional regulation of SR-BI expression. Factors associated with cholestasis appear to be involved in transcriptional control of intestinal SR-BI expression. The role of SR-BI in the cholesterol-absorption process remains to be defined.
I型清道夫受体B类(SR-BI)在啮齿动物的肠道中表达,并且有人提出它参与膳食胆固醇的吸收。本研究的目的是确定在胆汁向肠道输送改变且胆固醇吸收受损的动物模型中,肠道SR-BI的表达是否受到影响。测定了对照、胆管结扎和胆汁转流大鼠以及对照和胆管结扎小鼠近端和远端小肠中SR-BI蛋白和mRNA水平。研究了两种基因改变的小鼠模型:产生无磷脂/胆固醇胆汁的多药耐药2 P-糖蛋白缺陷[Mdr2(-/-)]小鼠,以及胆汁盐池在质量和数量上均有变化的胆固醇7α-羟化酶缺陷[Cyp7a(-/-)]小鼠。使用双同位素比率法对胆固醇吸收效率进行了定量。SR-BI存在于对照大鼠和小鼠肠上皮细胞的顶端膜,并且在小肠近端比远端更丰富。在胆管结扎的动物中,SR-BI蛋白水平几乎不存在,mRNA水平下降了约50%。胆汁转流的大鼠、Mdr2(-/-)小鼠和Cyp7a(-/-)小鼠肠道SR-BI蛋白水平降低,而mRNA水平未受影响。在胆管结扎和胆汁转流的动物以及Cyp7a(-/-)小鼠中,胆固醇吸收减少了>90%,而Mdr2(-/-)小鼠显示约减少50%。本研究表明,SR-BI在大鼠和小鼠肠上皮细胞的顶端膜表达,主要在胆固醇吸收最大的上肠道,并且表明胆汁成分在SR-BI表达的转录后调控中起作用。与胆汁淤积相关的因素似乎参与肠道SR-BI表达的转录控制。SR-BI在胆固醇吸收过程中的作用仍有待确定。